Lyndal K. Hesterberg
2017
In 2017, Lyndal K. Hesterberg earned a total compensation of $299.4K as Senior VP of Research and Development at Oncocyte Corp, a 55% decrease compared to previous year.
Compensation breakdown
| Bonus | $33,720 |
|---|---|
| Option Awards | $47,378 |
| Salary | $210,750 |
| Other | $7,521 |
| Total | $299,369 |
Hesterberg received $210.8K in salary, accounting for 70% of the total pay in 2017.
Hesterberg also received $33.7K in bonus, $47.4K in option awards and $7.5K in other compensation.
Rankings
In 2017, Lyndal K. Hesterberg's compensation ranked 13,349th out of 14,666 executives tracked by ExecPay. In other words, Hesterberg earned more than 9.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,349 out of 14,666 | 9th |
Division Manufacturing | 5,254 out of 5,772 | 9th |
Major group Chemicals And Allied Products | 1,901 out of 2,075 | 8th |
Industry group Drugs | 1,585 out of 1,731 | 8th |
Industry In Vitro and In Vivo Diagnostic Substances | 65 out of 72 | 10th |
Source: SEC filing on July 27, 2018.
Hesterberg's colleagues
We found three more compensation records of executives who worked with Lyndal K. Hesterberg at Oncocyte Corp in 2017.